Care One Migraine Relief Tablet, Film Coated
NDC Package 41520-374-78

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Care One Migraine Relief (acetaminophen, aspirin, caffeine) tablets is •do not use more than directed•adults: take 2 caplets with a glass of water•if symptoms persist or worsen, ask your doctor•do not take more than 2 caplets in 24 hours, unless directed by a doctor•under 18 years of age: ask a doctor. This formulation utilizes a tablet, film coated delivery system. Marketed by American Sales Company, this product is identified by NDC 41520-374 and is authorized under FDA application ANDA075794.

Identification & Billing

NDC Package Code
41520-374-78
Package Description
1 BOTTLE in 1 CARTON / 100 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
41520037478
RxNorm Crosswalk
  • RxCUI: 308297 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet
  • RxCUI: 308297 - APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet

Clinical Specifications

Proprietary Name
Care One Migraine Relief
Non-Proprietary Name
Acetaminophen, Aspirin, Caffeine
Substance Name
Acetaminophen; Aspirin; Caffeine
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
•do not use more than directed•adults: take 2 caplets with a glass of water•if symptoms persist or worsen, ask your doctor•do not take more than 2 caplets in 24 hours, unless directed by a doctor•under 18 years of age: ask a doctor

Regulatory & Marketing

Labeler Name
American Sales Company
Product Type
Human Otc Drug
FDA Application #
ANDA075794
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-13-2004
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (41520-374). Click a package code to view its specific billing and regulatory data.

1 BOTTLE in 1 CARTON / 24 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 41520-374-78 identifies a specific commercial package of 1 bottle in 1 carton / 100 tablet, film coated in 1 bottle of Care One Migraine Relief, a human over the counter drug labeled by American Sales Company. This tablet, film coated is formulated for oral use and contains acetaminophen; aspirin; caffeine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by American Sales Company on April 13, 2004. The current certification is valid through December 31, 2027.

How is this American Sales Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 41520037478. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
41520-374-78
11-Digit CMS (5-4-2)
41520-0374-78

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.